In toxin-induced PD mouse models, DA-JC1, a novel dual GLP-1/GIP receptor agonist, improved motor impairment, increased the number of dopaminergic neurons in the substantia nigra, enhanced BDNF levels, and modulated apoptosis signaling pathways by altering the expression of Bax and Bcl-2 [89, 90]
Rothhammer, V
In a study of eight men receiving 1,000 milligrams of glutathione before exercise, the glutathione group performed better, felt less fatigued, and had lower blood lactic acid levels than the placebo controlled group
No side effects, down 54 pounds since September
Beyond the formal trial period, thousands of patients worldwide have continued semaglutide therapy for 12, 18, and even 24+ months with sustained metabolic improvements